08/02/2024

EuropaBio welcomes and warns on New Genomic Techniques European Parliament vote

The New Genomic Techniques (NGTs) legislation vote in the European Parliament is a welcome modernisation of Europe’s biotechnology innovation, food security and climate change response. However, EuropaBio red flags the dangerous fragmentation and weakening of industrial policy with the ban on patenting of NGT plants.
04/09/2023

Factsheet – The Biotech Journey: From Bench to Patients

Innovations in healthcare biotechnology come from a vast array of stakeholders working with each other over extensive periods of time. In this factsheet we embark on a journey through the intricate ecosystem of healthcare biotechnology and highlight the time, expertise, and resources it takes to get innovative biotechnologies from bench to patient.
13/07/2023

Reform of the EU General Pharmaceutical Legislation Joint Position Paper on the Hospital Exemption Scheme for ATMPs

In the context of the revision of the EU General Pharmaceutical Legislation, this paper puts forward joint recommendations from ARM (Alliance for Regenerative Medicine), EFPIA (European Federation of Pharmaceutical Industries and Associations), EuropaBio, EUCOPE (European Confederation of Pharmaceutical Entrepreneurs) and ISCT (International Society for Cell & Gene Therapy), for the reform of the Hospital Exemption (HE) scheme for Advanced Therapy Medicinal Products (ATMPs).
22/06/2023

bioMérieux joins EuropaBio: Advancing QC testing for innovative therapies

EuropaBio is pleased to announce that bioMérieux has joined the association as Corporate Member. bioMérieux is a family-owned biotechnology company founded in France. Since 1963, it has been at the forefront of ground-breaking advancements in the field of in vitro diagnostics, making significant contributions to improving public health worldwide. bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.
23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023

Brussels, May 2023 – EuropaBio flies the flag for European biotechnology at the highly anticipated BIO International Convention 2023, scheduled to take place in Boston, MA on 5-8 June and one of the largest biotech industry events worldwide with 100+ interactive sessions across 4 days covering all aspects of business, policy, trade and science.